Reduced contrast sensitivity, pattern electroretinogram ratio, and diminished a-wave amplitude in patients with major depressive disorder Evelyn B. N. FriedelLudger Tebartz van ElstKathrin Nickel Original Paper Open access 28 May 2024
Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables Victoria EspinosaAlana BagaevaSusana Ochoa Original Paper 28 May 2024
Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses Weiyan WangXingjie PengRenrong Wu Original Paper 27 May 2024
Effectiveness of cannabis use and cannabis use disorder interventions: a European and international data synthesis Jason P. ConnorJakob MantheyDaniel Stjepanović Invited Review Open access 23 May 2024
Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users Arilton Martins FonsecaRafael Guimarães dos SantosEliana Rodrigues Original Paper 23 May 2024
Facial emotion recognition function and white matter microstructural alterations in drug-naive, comorbidity-free autism Xing SuSiuching KatJing Liu Original Paper 22 May 2024
Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations Tom P. FreemanEdward BeechingRoumen Sedefov Original Paper Open access 21 May 2024
Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality Zack Y. ShanAdem T. CanJim Lagopoulos Original Paper Open access 21 May 2024
Assessing the joint effects of mitochondrial genes and physical activity on the psychiatric phenotype of subjective well-being based on the UK Biobank data Panxing ShiBingyi WangYan Wen Original Paper 20 May 2024
Correction: The association between childhood trauma and tobacco smoking in patients with psychosis, unaffected siblings, and healthy controls Justine de WithHeleen S. van der HeijdenFrederike Schirmbeck Correction Open access 16 May 2024
Glutamate imbalance in key structure of the default mode network in adults with attention-deficit/hyperactivity disorder Marcos VinÃcius VidorEduardo Schneider VitolaEugenio Horacio Grevet Original Paper 16 May 2024
Correction: Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis Stefan FritzeGeva A. BrandtDusan Hirjak Correction Open access 13 May 2024
Characterization of cognitive symptoms in post COVID-19 patients Michael RuzickaSimone SachenbacherKristina Adorjan Original Paper Open access 13 May 2024
Effects of web-based adapted physical activity on hippocampal plasticity, cardiorespiratory fitness, symptoms, and cardiometabolic markers in patients with schizophrenia: a randomized, controlled study E. LerouxM. TréhoutS. Dollfus Original Paper 13 May 2024
Three distinct patterns of mental health response following accidents in mountain sports: a follow-up study of individuals treated at a tertiary trauma center Hanna Veronika SalvottiPiotr TymoszukKatharina Hüfner Original Paper Open access 10 May 2024
Advising activity—knowledge, attitudes, beliefs, and behaviors regarding the recommendation of physical activity in clinical psychologists Moritz Bruno PetzoldFelix BetzlerAntonia Bendau Original Paper Open access 07 May 2024
Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study Rachel LeesWill LawnTom P. Freeman Original Paper Open access 06 May 2024
Smoking may increase the usage of antidepressant: evidence from genomic perspective analysis Yucai QuZhiqiang DuHaohao Zhu Original Paper 03 May 2024
All available diagnostic and therapeutic options should be fully exploited in order to quickly identify and optimally treat neuropathic pain in long-COVID Josef Finsterer Letter to the Editor 02 May 2024
Persistent negative symptoms in young people at clinical high risk of psychosis treated with an Italian early intervention program: a longitudinal study Camilla RicciEmanuela LeuciLorenzo Pelizza Original Paper Open access 26 April 2024
Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023 Li-yuan ZhaoGuang-fen ZhangJian-jun Yang Original Paper 25 April 2024
Altered patterns of dynamic functional connectivity of brain networks in deficit and non-deficit schizophrenia Biying YeYiqiao WuXiangrong Zhang Original Paper 25 April 2024
Bright light therapy versus physical exercise to prevent co-occurring depression in adolescents and young adults with attention-deficit/hyperactivity disorder: a multicentre, three-arm, randomised controlled, pilot phase-IIa trial Jutta S. MayerLaura KohlhasChristine M. Freitag Original Paper Open access 16 April 2024
Cognitive horizons in chronic pain: unraveling neuroscientific insights and innovative interventions for fibromyalgia Jie SunXiaoxing LiuLin Lu Editorial 15 April 2024
The boon and bane of nitrous oxide Golo KronenbergGeorgios SchoretsanitisSebastian Olbrich Invited Review Open access 13 April 2024
Criminal behavior in alcohol-related dementia and Wernicke–Korsakoff syndrome: a Nationwide Register Study Anniina PalmTiina TalaslahtiHannu Koponen Original Paper Open access 13 April 2024
Beneficial and adverse effects of ketamine and its enantiomers, and the underlying mechanisms of ECT and rTMS efficacy Kenji Hashimoto Editorial 12 April 2024 Pages: 755 - 757
Diminished differentiation of rewards in individuals at clinical high-risk for psychosis D. N. PrattM. T. TreadwayV. A. Mittal Original Paper 10 April 2024
Genetic predisposition for negative affect predicts mental health burden during the COVID-19 pandemic Alicia M. SchoweMalvika GodaraElisabeth B. Binder Original Paper Open access 08 April 2024
Effects of an integrative multimodal inpatient program on fatigue and work ability in patients with Post-COVID Syndrome—a prospective observational study Sarah SchmidChristine UeckerJost Langhorst Original Paper 05 April 2024
Change in brain activation after transcranial pulsed electromagnetic fields in treatment-resistant depression Sjoerd M. van BelkumEsther M. OpmeerAndré Aleman Original Paper Open access 05 April 2024
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial Siegfried KasperHans-Peter VolzErich Seifritz Original Paper Open access 01 April 2024
Sex differences in anhedonia in bipolar depression: a resting-state fMRI study Xiaoqin WangYi XiaQing Lu Original Paper 01 April 2024
Stacked artificial neural network to predict the mental illness during the COVID-19 pandemic Usharani Bhimavarapu Original Paper 01 April 2024
Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case–control study Dian-Jeng LiShih-Jen TsaiMu-Hong Chen Original Paper Open access 30 March 2024
Comparing the latent state–trait structure of the PANSS in cariprazine-medicated and placebo-controlled patients with acute schizophrenia Jana S. KrücklKároly AcsaiChristian G. Huber Original Paper Open access 29 March 2024
Predictors of adherence to exercise interventions in people with schizophrenia Rebecca SchwaigerIsabel MaurusLukas Roell Original Paper Open access 29 March 2024
Interaction between baseline BMI and baseline disease severity predicts greater improvement in negative symptoms in first-episode schizophrenia Xiaobing SunRuiqing HeXiang Yang Zhang Original Paper 27 March 2024
Childhood abuse and craving in methamphetamine-dependent individuals: the mediating role of alexithymia Jiajing ChenDong Mei WangXiang Yang Zhang Original Paper 26 March 2024
From pathogenesis of stress-related mental disorders to treatment: beyond the brain Xiaoxing LiuLin Lu Editorial 22 March 2024 Pages: 473 - 474
Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis Stefan FritzeGeva A. BrandtDusan Hirjak Original Paper Open access 20 March 2024
Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients Nina Kim BekierUlrich FrischknechtDerik Hermann Original Paper 19 March 2024
Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication Natalia Mansur HaddadLeonardo Peroni De JesusAlexandre Andrade Loch Original Paper 19 March 2024
Post-COVID breathlessness: a mathematical model of respiratory processing in the brain Dina von WerderFranziska RegnathStefan Glasauer Original Paper Open access 19 March 2024
The impact of aerobic endurance training on cognitive performance in schizophrenic inpatients in a clinical routine setting Elisa SemlerFlorian HerpichAlexander Brunnauer Original Paper 19 March 2024
Cannabis use, health problems, and criminal offences in Germany: national and state-level trends between 2009 and 2021 Jakob MantheySinja KlingerLarissa Schwarzkopf Original Paper Open access 19 March 2024
Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database Marion IstvanMélanie DuvalCaroline Victorri-Vigneau Original Paper 18 March 2024
Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder Mu-Hong ChenYa-Mei BaiShih-Jen Tsai Original Paper Open access 16 March 2024
Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature Daniel FeingoldDana Tzur BitanEva Hoch Original Paper 16 March 2024
Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score Fernando FacalManuel ArrojoJavier Costas Original Paper 16 March 2024
